NCT01285427View on ClinicalTrials.gov

Clinical Protocol SeCore, uTYPE and 3500 Dx System

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Human Leukocyte Antigens (HLA)
Sponsors
All Listed Sponsors
lead

Life Technologies Corporation

INDUSTRY